ATRC logo

ATRC
Atricure Inc

391
Mkt Cap
$1.62B
Volume
952,230.00
52W High
$43.18
52W Low
$28.29
PE Ratio
-53.70
ATRC Fundamentals
Price
$32.97
Prev Close
$32.65
Open
$32.65
50D MA
$38.96
Beta
1.06
Avg. Volume
534,727.60
EPS (Annual)
-$0.9517
P/B
3.41
Rev/Employee
$357,928.46
$1,389.06
Loading...
Loading...
Poll

Earnings Recap

• Reported GAAP EPS of $0.04 up 112.12% YoY • Reported revenue of $140.5M up 13.05% YoY • AtriCure projects full year 2026 revenue of $600M to $610M, reflecting 12% to 14% growth, with adjusted EBITDA of $80 million to $82 million, and adjusted EPS of $0.09 to $0.15.

Bullish

AtriCure achieved strong Q4 and full year 2025 revenue growth, driven by expanding product adoption and improved profitability. The company is advancing key innovation and strategic initiatives.

Bearish

AtriCure experienced declines in minimally invasive device revenue and a full year net loss of -$11.4M. The company also faces competition from new technologies and regulatory clearance risks.

Latest ATRC News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.